Varex Imaging Corporation

NASDAQ:VREX

Medical - Devices

Healthcare
$18.15 +3.33%

+$0.34 today

Market cap
$770.71M
Beta
0.90
P/E (TTM)
-5.3
EPS (TTM)
-$1.97
52W Low $6.76High $14.57

Volume 0.73M

Average 0.36M

VREX Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

Varex Imaging CorporationNASDAQ: VREX

Cost of Revenue · Q2 FY2026 · quarter ended Apr 2026

Cost of revenue grows in line with its trailing trend

Q2 FY2026 cost of revenue of $143.4M rose 5.3% year over year, ahead of the +3.9% change in trailing-twelve-month cost of revenue. Sequentially, it rose 2.6% from the prior quarter. Over 3 fiscal years it compounded at -1.3% a year.

Context

  • Cost of revenue amounted to 65.6% of revenue in FY2025, down 2.7 pp from a year earlier.
  • Cost of revenue increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +5.3% holds above the trailing-twelve-month pace of +3.9%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterApr 2026
$143.4M+2.6% QoQ
Last fiscal yearOct 2025
$554.1M+0.0% YoY
LTMApr 2026
$569.8M+3.9% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+5.3%——
1 year+0.0%——
3-year CAGR-1.3%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
554.1M USD
Year-over-year change
+0.0%
4-year CAGR
+0.3%

Cost of Revenue vs competitors

How VREX compares with its peers on the latest reported figures

  • VREX's LTM Apr 2026 cost of revenue of $569.8M is the 4th highest of the 5 companies compared; the peer median is $1.53B.
  • Its year-over-year change of +3.9% is the 4th highest of 5, against a peer median of +5.3%.
  • Cost of revenue amounts to 66.4% of revenue for VREX, versus a peer median of 61.9%.
VREX Competitors Peer median
Cost of Revenue for VREX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
GEHCGE HealthCare Technologies Inc.LTM Jun 2026$11.56B -1.0%+3.5%57.1%
BRKRBruker CorporationLTM Jun 2026$1.87B +4.7%+14.9%53.3%
OSISOSI Systems, Inc.LTM Jun 2026$1.19B +5.9%+12.1%66.8%
VREXVarex Imaging CorporationLTM Apr 2026$569.8M +3.9%-1.3%66.4%
NNOXNano-X Imaging Ltd.LTM Dec 2025$25.81M +17.4%+18.6%198.2%
Peer median (excluding VREX) $1.53B+5.3%+13.5%61.9%

Competitors are the stored peer set for VREX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Oct 2021
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Oct 2025
Revenue818.1M859.4M893.4M811M844.6M
Cost of Revenue546.6M575.9M603.1M554.1M554.1M
Gross Profit271.5M283.5M290.3M256.9M290.5M
Gross Margin33.2%33.0%32.5%31.7%34.4%
Research & Development71.9M77M84.8M87M91.1M
Selling, General & Admin125.5M118.3M128.4M137.8M133.3M
Operating Expenses197.4M195.3M213.2M224.8M318.3M
Depreciation & Amortization37.3M33.6M33.2M31.1M27.2M
EBITDA104.5M114.5M94.7M62.9M3.5M
EBITDA Margin12.8%13.3%10.6%7.8%0.4%
Operating Income74.1M88.2M77.1M32.1M(27.8M)
Operating Margin9.1%10.3%8.6%4.0%-3.3%
Interest Income100K400K3.7M7.3M8.5M
Interest Expense43.4M41M29.3M31.1M35.5M
Other Income / Expenses(45.5M)(43.7M)(45.8M)(27.1M)(31.4M)
Income Before Tax28.6M44.5M31.3M5M(59.2M)
Pre-Tax Margin3.5%5.2%3.5%0.6%-7.0%
Income Tax Expense10.7M13.7M(16.6M)52.2M10.7M
Net Income17.4M30.3M47.4M(47.7M)(70.3M)
Net Margin2.1%3.5%5.3%-5.9%-8.3%
EPS (Basic)0.440.761.20(1.17)(1.70)
EPS (Diluted)0.430.730.96(1.17)(1.70)
Weighted Avg Shares39.3M39.8M40.3M40.8M41.4M
Weighted Avg Shares (Diluted)40.3M41.6M50.3M40.8M41.4M

Varex Imaging Corporation

NASDAQ:VREX

Intrinsic Alpha fair value

Locked

Current Price

$18.15

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.